Epigallocatechin‐3‐gallate sensitises multidrug‐resistant oral carcinoma xenografts to vincristine sulfate

Epigallocatechin‐3‐gallate sensitises multidrug‐resistant oral carcinoma xenografts to vincristine sulfate

Oral squamous cell carcinoma (OSCC) is a very aggressive malignancy, and 50% of patients who receive curative treatment die from the disease or related complications within 5 years. Epigallocatechin‐3‐gallate (EGCG) is the most abundant bioactive ingredient of tea polyphenols in green tea and has an...

Full description

Bibliographic Details
Main Authors: Li Chen, Xianwen Guo, Ye Hu, Li Li, Gang Liang, Guo Zhang
Format: Article
Language:English
Published: Wiley 2020-07-01
Series:FEBS Open Bio
Subjects:
angiogenesis
epigallocatechin‐3‐gallate
multidrug resistance
oral squamous cell carcinoma
tumour growth
vincristine sulfate
Online Access:https://doi.org/10.1002/2211-5463.12905

Internet

https://doi.org/10.1002/2211-5463.12905

Similar Items